Business Overview
Turning Today’s Clinical Trials Into Tomorrow’s Therapies
With 85% of people seeking cancer care in the community where they live, it’s important that every person facing cancer has access to the most advanced therapies through clinical trials without having to travel far from home.
Through Sarah Cannon Research Institute (SCRI), we are expanding access to potentially life-saving oncology therapies and clinical trial opportunities at the community level.
Our Focus Areas
We provide partners, physicians and patients access to:
End-to-end clinical trial site management and contract research services
A network of globally recognized cancer experts
Robust personalized medicine program, powered by Genospace
SCRI at a Glance
We support an expansive clinical research network.
1.3k+
There are more than 1,300 physicians participating in research across SCRI’s network.
~3.4k
Approximately 3,400 patients participate in our treatment trials each year.
850+
We have conducted more than 850 first-in-human trials to date.
200+
We have over 200 locations in more than 20 states.
Explore our SCRI Stories & Insights
News
SCRI News
-
McKesson Corporation Completes Acquisition of Core Ventures
-
The US Oncology Network Extends its Reach in Illinois as Illinois CancerCare Joins The Network
-
McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures
-
The US Oncology Network Expands its Tennessee Service Area as Tennessee Cancer Specialists Joins The Network
-
Real-World Research Presented at ASCO 2024 Indicates Clinical Trial Participation by Older Adults with Cancer Does Not Affect Emergency Room Visits or Hospice Enrollment
Learn More About McKesson’s Solutions
Oncology & Specialty Solutions
Our focus is on collaborating with our partners and healthcare providers so that the latest advancements in cancer treatment reach those who need them most.
Learn more about McKesson’s oncology and specialty solutions that are accelerating specialized care.
Biopharma Capabilities
We are the only oncology research organization of its kind to offer end-to-end clinical trial site management, contract research services for biopharma and personalized medicine advisory services in one place.
Learn more about McKesson’s biopharma capabilities that are advancing healthcare forward.